Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: A Canadian population-based study

British Journal of Cancer

Volumn 109, Issue 5, 2013, Pages 1287-1290

  Beiggi, S ^a,b   Johnston, J B ^a,b,c   Seftel, M D ^a,c   Pitz, M W ^a   Kumar, R ^a,c   Banerji, V ^a,b,c   Griffith, E J ^a,c   Gibson, S B ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NONE   (Canada)

Author keywords

chronic lymphocytic leukaemia; follicular lymphoma; epidemiology; second malignancies; non melanoma skin cancers; treatment

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SECOND CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANADA; COHORT STUDIES; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84883740125     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.381     Document Type: Article

References (22)

1. Chen AC, Halliday GM, Damian DL (2013) Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology 45(3): 331-341.
2. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-4997. (Pubitemid 26189840)
3. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509.
4. Garc?́a JB, Suárez-Varela MM, Vilata JJ,Marquina A, Pallardó L, Crespo J (2013) Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol 93: 422-427.
5. Greene MH, Hoover RN, Fraumeni Jr JF (1978) Subsequent cancer in patients with chronic lymphocytic leukemia-a possible immunologic mechanism. J Natl Cancer Inst 61: 337-340. (Pubitemid 9019566)
6. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456.
7. Johnston JB, Gibson SB, Seftel MD (2009) Chronic lymphocytic leukemia. In: Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B (eds) Wintrobe's Clinical Hematology. Lippincott Williams & Wilkins: Baltimore, pp 2256-2275.
8. Linet MS, Van Natta ML, Brookmeyer R, Khoury MJ, McCaffrey LD, Humphrey RL, Szklo M (1989) Familial cancer history and chronic lymphocytic leukemia. A case-control study. Am J Epidemiol 130: 655-664. (Pubitemid 19240194)
9. Manusow D, Weinerman BH (1975) Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 232: 267-269.
10. Molica S (2005) Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma 46: 49-54.
11. Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LAG, Fraumeni Jr JF (2010) Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol 28: 4935-4944.
12. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV (2005) Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 14: 2584-2590. (Pubitemid 41752719)
13. Royle JA, Baade PD, Joske D, Girschik J, Fritschi L (2011a) Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 105: 1076-1081.
14. Royle JS, Baade P, Joske D, Fritschi L (2011b) Risk of second cancer after lymphohematopoietic neoplasm. Int J Cancer 129: 910-919.
15. Schöllkopf C, Rosendahl D, Rostgaard K, Pipper C, Hjalgrim H (2007) Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer 121: 151-156. (Pubitemid 46753863)
16. Seftel MD, Demers AA, Banerji V, Gibson SB, Morales C, Musto G, Pitz MW, Johnston JB (2009) High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. Leuk Res 33: 1463-1468.
17. Solomon BM, Rabe KG, Slager SL, Brewer JD, Cerhan JR, Shanafelt TD (2013) Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. J Clin Oncol 31: 930-937.
18. Teruya-Feldstein J, Greene J, Cohen L, Popplewell L, Ellis NA, Offit K (2002) Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. Leuk Lymphoma 43: 1619-1626. (Pubitemid 34823483)
19. Tsai H-T, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, Marti GE, Albitar M, Ghia P, Rajkumar SV, Landgren O (2009) Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 114: 4928-4932.
20. Tsimberidou A-M, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ (2009) Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 27: 904-910.
21. Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do K-A, Garcia-Manero G, Cortes J, Thomas D, Koller C, Burger J, Lerner S, Kantarjian H, Keating M (2009) Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment. J Clin Oncol 27: 1637-1643.
22. Yoon J-Y, Lafarge S, Dawe D, Lakhi S, Kumar R, Morales C, Marshall A, Gibson SB, Johnston JB (2012) Association of interleukin-6 and interleukin-8 with poor prognosis in elderly chronic lymphocytic leukemia patients. Leuk Lymphoma 53(9): 1735-1742.